Don't ask, don't tell: a systematic review of the extent to which participant characteristics are reported in social anxiety treatment studies

References

• *Aarre, T. F. (2003). Phenelzine efficacy in refractory social anxiety disorder: A case series. Nordic Journal of Psychiatry, 57(4), 313–315.
   PubMed Web of Science ®Google Scholar
• *Abramowitz, J. S., Moore, E. L., Braddock, A. E., & Harrington, D. L. (2009). Self-help cognitive-behavioral therapy with minimal therapist contact for social phobia: A controlled trial. Journal of Behavior Therapy and Experimental Psychiatry, 40(1), 98–105. doi:10.1016/j.jbtep.2008.04.004
   PubMed Web of Science ®Google Scholar
• *Adler, L. A., Liebowitz, M., Kronenberger, W., Qiao, M., Rubin, R., Hollandbeck, M., … Durell, T. (2009). Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Depression and Anxiety, 26(3), 212–221.
   PubMed Web of Science ®Google Scholar
• *Alden, L. E., & Taylor, C. T. (2011). Relational treatment strategies increase social approach behaviors in patients with generalized social anxiety disorder. Journal of Anxiety Disorders, 25(3), 309–318. doi:10.1016/j.janxdis.2010.10.003
   PubMed Web of Science ®Google Scholar
• *Alfano, C. A., Pina, A. A., Villalta, I. K., Beidel, D. C., Ammerman, R. T., & Crosby, L. E. (2009). Mediators and moderators of outcome in the behavioral treatment of childhood social phobia. Journal of The American Academy of Child & Adolescent Psychiatry, 48(9), 945–953. doi:10.1097/CHI.0b013e3181af8216
   PubMed Web of Science ®Google Scholar
• *Allgulander, C., Mangano, R., Zhang, J., Dahl, A. A., Lepola, U., Sjödin, I., & Emilien, G. (2004). Efficacy of Venlafaxine ER in patients with social anxiety disorder: A double-blind, placebo-controlled, parallel-group comparison with paroxetine. Human Psychopharmacology: Clinical and Experimental, 19(6), 387–396. doi:10.1002/hup.602
   PubMed Web of Science ®Google Scholar
• *Allgulander, C., & Nilsson, B. (2001). A prospective study of 86 new patients with social anxiety disorder. Acta Psychiatrica Scandinavica, 103(6), 447–452. doi:10.1034/j.1600-0447.2001.00320.x
   PubMed Web of Science ®Google Scholar
• Altman, D.G., Schulz, K.F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., … Lang, T. (2001). The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Annals of Internal Medicine, 134, 663–694.
   PubMed Web of Science ®Google Scholar
• American Psychological Association. (2003). Guidelines on multicultural education, training, research, practice, and organizational change for Psychologists. American Psychologist, 58, 377–402.
   PubMed Web of Science ®Google Scholar
• American Psychological Association, Council of Editors. (1952). Publication manual of the American Psychological Association. Psychological Bulletin, 49(Suppl., Pt 2), 389–449.
   PubMedGoogle Scholar
• *Amir, N., Beard, C., Taylor, C. T., Klumpp, H., Elias, J., Burns, M., & Chen, X. (2009). Attention training in individuals with generalized social phobia: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 77(5), 961–973. doi:10.1037/a0016685
   PubMed Web of Science ®Google Scholar
• *Amir, N., & Taylor, C. T. (2012). Interpretation training in individuals with generalized social anxiety disorder: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 80, 497–511.
   Google Scholar
• *Amir, N., Taylor, C. T., & Donohue, M. C. (2011). Predictors of response to an attention modification program in generalized social phobia. Journal of Consulting and Clinical Psychology, 79(4), 533–541. doi:10.1037/a0023808
   PubMed Web of Science ®Google Scholar
• *Anderson, P., Rothbaum, B. O., & Hodges, L. F. (2003). Virtual reality exposure in the treatment of social anxiety. Cognitive and Behavioral Practice, 10(3), 240–247. doi:10.1016/s1077-7229(03)80036-6
   Web of Science ®Google Scholar
• *Anderson, P., Zimand, E., Schmertz, S. K., & Ferrer, M. (2007). Usability and utility of a computerized cognitive-behavioral self-help program for public speaking anxiety. Cognitive and Behavioral Practice, 14(2), 198–207. doi:10.1016/j.cbpra.2006.02.006
   Web of Science ®Google Scholar
• *Andrews, G., Davies, M., & Titov, N. (2011). Effectiveness randomized controlled trial of face to face versus Internet cognitive behaviour therapy for social phobia. Australian and New Zealand Journal of Psychiatry, 45(4), 337–340. doi:10.3109/00048674.2010.538840
   PubMed Web of Science ®Google Scholar
• APA Publications and Communications Board Working Group on Journal Article Reporting Standards. (2008). Reporting standards for research in psychology: Why do we need them? What might they be? American Psychologist, 63, 839–851.
   PubMed Web of Science ®Google Scholar
• *Argyropoulos, S. V., Hood, S. D., Adrover, M., Bell, C. J., Rich, A. S., Nash, J. R., … Nutt, D. J. (2004). Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder. Biological Psychiatry, 56(7), 503–509.
   PubMed Web of Science ®Google Scholar
• *Asakura, S., Tajima, O., & Koyama, T. (2007). Fluvoxamine treatment of generalized social anxiety disorder in Japan: A randomized double-blind, placebo-controlled study. International Journal of Neuropsychopharmacology, 10(2), 263–274. doi:10.1017/S1461145706006602
   PubMed Web of Science ®Google Scholar
• *Ashbaugh, A., Antony, M. M., Liss, A., Summerfeldt, L. J., McCabe, R. E., & Swinson, R. P. (2007). Changes in perfectionism following cognitive-behavioral treatment for social phobia. Depression and Anxiety, 24(3), 169–177. doi:10.1002/da.20219
   PubMed Web of Science ®Google Scholar
• *Atmaca, M., Kuloglu, M., Tezcan, E., & Unal, A. (2002). Efficacy of citalopram and moclobemide in patients with social phobia: Some preliminary findings. Human Psychopharmacology: Clinical & Experimental, 17(8), 401–405. doi:10.1002/hup.436
   PubMed Web of Science ®Google Scholar
• *Atmaca, M., Tezcan, E., Kuloglu, M., Ustundag, B., & Tunckol, H. (2004). Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment. European Archives of Psychiatry and Clinical Neuroscience, 254(4), 231–235. doi:10.1007/s00406-004-0484-3
   PubMed Web of Science ®Google Scholar
• *Baer, S., & Garland, E. J. (2005). Pilot study of community-based cognitive behavioral group therapy for adolescents with social phobia. Journal of the American Academy of Child & Adolescent Psychiatry, 44(3), 258–264. doi:10.1097/00004583-200503000-00010
   PubMed Web of Science ®Google Scholar
• *Baldwin, D. S., Stein, D. J., Dolberg, O. T., & Bandelow, B. (2009). How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder, or social anxiety disorder? An exploration of the randomised controlled trial database. Human Psychopharmacology: Clinical and Experimental, 24(4), 269–275. doi:10.1002/hup.1019
   PubMed Web of Science ®Google Scholar
• *Barnett, S. D., Kramer, M. L., Casat, C. D., Connor, K. M., & Davidson, J. R. T. (2002). Efficacy of olanzapine in social anxiety disorder: A pilot study. Journal of Psychopharmacology, 16(4), 365–368.
   PubMed Web of Science ®Google Scholar
• *de la Barquera, J. S. (2008). Estudio controlado doble-ciego con clonazepam y placebo en pacientes con trostorno de ansiedad social: Double-blind controlled study with clonazapam and placebo in social anxiety disorder. Salud Mental, 31(4), 299–306.
   Web of Science ®Google Scholar
• *Beard, C. (2011). Cognitive bias modification for anxiety: Current evidence and future directions. Expert Review of Neurotherapeutics, 11(2), 299–311. doi:10.1586/ern.10.194.
   PubMed Web of Science ®Google Scholar
• *Beidel, D. C., Turner, S. M., Sallee, F. R., Ammerman, R. T., Crosby, L. A., & Pathak, S. (2007). SET-C versus fluoxetine in the treatment of childhood social phobia. Journal of The American Academy of Child & Adolescent Psychiatry, 46(12), 1622–1632. doi:10.1097/chi.0b013e318154bb57
   PubMed Web of Science ®Google Scholar
• *Bell, C. J., Colhoun, H. C., Carter, F. A., & Frampton, C. M. (2012). Effectiveness of computerised cognitive behaviour therapy for anxiety disorders in secondary care. Australian and New Zealand Journal of Psychiatry, 46(7), 630–640. doi:10.1177/0004867412437345
   PubMed Web of Science ®Google Scholar
• *Benjamin, C., Puleo, C., & Kendall, P. (2011). Informant agreement in treatment gains for child anxiety. Child & Family Behavior Therapy, 33(3), 199–216. doi:10.1080/07317107.2011.595987
   Web of Science ®Google Scholar
• *Bergamaschi, M. M., Queiroz, R. H. C., Chagas, M. H. N., de Oliveira, D. C. G., De Martinis, B. S., Kapczinski, F., … Crippa, J. A. S. (2011). Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology, 36(6), 1219–1226.
   PubMed Web of Science ®Google Scholar
• *Berger, T., Hohl, E., & Caspar, F. (2009). Internet-based treatment for social phobia: A randomized controlled trial. Journal of Clinical Psychology, 65(10), 1021–1035. doi:10.1002/jclp.20603
   PubMed Web of Science ®Google Scholar
• *Berry, A. C., Rosenfield, D., & Smits, J. J. (2009). Extinction retention predicts improvement in social anxiety symptoms following exposure therapy. Depression and Anxiety, 26(1), 22–27. doi:10.1002/da.20511
   PubMed Web of Science ®Google Scholar
• *Blanco, C., Heimberg, R. G., Schneier, F. R., Fresco, D. M., Chen, H., Turk, C. L., … Liebowitz, M. R. (2010). A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder. Archives of General Psychiatry, 67(3), 286–295.
   PubMed Web of Science ®Google Scholar
• *Book, S. W., Thomas, S. E., Randall, P. K., & Randall, C. L. (2008). Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder. Journal of Anxiety Disorders, 22(2), 310–318. doi:10.1016/j.janxdis.2007.03.001
   PubMed Web of Science ®Google Scholar
• *Brozovich, F. A., & Heimberg, R. G. (2011). A treatment-refractory case of social anxiety disorder: Lessons learned from a failed course of cognitive-behavioral therapy. Cognitive and Behavioral Practice, 18(3), 316–325. doi:10.1016/j.cbpra.2010.07.003
   Web of Science ®Google Scholar
• *Büch, H., & Döpfner, M. (2011). Behandlung sozialer Ängste im kindesalter mit einem individualisierten kognitiv-behavioralen therapieprogramm (THAZ-soziale ängste)-konzeption und ergebnisse einer pilotstudie. Verhaltenstherapie, 21(1), 41–47. doi:10.1159/000324312
   Web of Science ®Google Scholar
• *Buckner, J. D., & Schmidt, N. B. (2009). A randomized pilot study of motivation enhancement therapy to increase utilization of cognitive–behavioral therapy for social anxiety. Behaviour Research and Therapy, 47(8), 710–715. doi:10.1016/j.brat.2009.04.009
   PubMed Web of Science ®Google Scholar
• Campbell, D. T., & Stanley, J. (1963). Experimental and quasi-experimental designs for research and teaching. In N. L. Gaye (Eds.), Handbook of research on teaching (pp. 171–246). Chicago, IL: Rand McNally.
   Google Scholar
• *Carlbring, P., Gunnarsdóttir, M., Hedensjö, L., Andersson, G., Ekselius, L., & Furmark, T. (2007). Treatment of social phobia: Randomised trial of internet-delivered cognitive-behavioural therapy with telephone support. The British Journal of Psychiatry, 190(2), 123–128. doi:10.1192/bjp.bp.105.020107
   PubMed Web of Science ®Google Scholar
• *Carlbring, P., Nordgren, L. B., Furmark, T., & Andersson, G. (2009). Long-term outcome of internet-delivered cognitive–behavioural therapy for social phobia: A 30-month follow-up. Behaviour Research and Therapy, 47(10), 848–850. doi:10.1016/j.brat.2009.06.012
   PubMed Web of Science ®Google Scholar
• *Cassimjee, N., Fouche, J.-P., Burnett, M., Lochner, C., Warwick, J., Dupont, P., … Carey, P. D. (2010). Changes in regional brain volumes in social anxiety disorder following 12 weeks of treatment with escitalopram. Metabolic Brain Disease, 25(4), 369–374.
   PubMed Web of Science ®Google Scholar
• *Cederlund, R., & Öst, L. (2011). Perception of threat in children with social phobia: Comparison to nonsocially anxious children before and after treatment. Journal of Clinical Child and Adolescent Psychology, 40(6), 855–863. doi:10.1080/15374416.2011.618448
   PubMed Web of Science ®Google Scholar
• *Chavira, D. A., & Stein, M. B. (2002). Combined psychoeducation and treatment with selective serotonin reuptake inhibitors for youth with generalized social anxiety disorder. Journal of Child and Adolescent Psychopharmacology, 12(1), 47–54. doi:10.1089/10445460252943560
   PubMed Web of Science ®Google Scholar
• *Chen, J., Nakano, Y., Ietzugu, T., Ogawa, S., Funayama, T., Watanabe, N., … Furukawa, T. A. (2007). Group cognitive behavior therapy for Japanese patients with social anxiety disorder: Preliminary outcomes and their predictors. BMC Psychiatry, 7, 69. doi:10.1186/1471-244X-7-69.
   Google Scholar
• *Codd III R. T., Twohig, M. P., Crosby, J. M., & Enno, A. (2011). Treatment of three anxiety disorder cases with acceptance and commitment therapy in a private practice. Journal of Cognitive Psychotherapy, 25(3), 203–217. doi:10.1891/0889-8391.25.3.203
   Google Scholar
• *Comer, J. S., Puliafico, A. C., Aschenbrand, S. G., McKnight, K., Robin, J. A., Goldfine, M. E., & Albano, A. M. (2011). A pilot feasibility evaluation of the calm program for anxiety disorders in early childhood. Journal of Anxiety Disorders, 26, 40–49.
   Google Scholar
• *Compton, S. N., Grant, P. J., Chrisman, A. K., Gammon, P. J., Brown, V. L., & March, J. S. (2001). Sertraline in children and adolescents with social anxiety disorder: An open trial. Journal of the American Academy of Child & Adolescent Psychiatry, 40(5), 564–571. doi:10.1097/00004583-200105000-00016
   PubMed Web of Science ®Google Scholar
• *Courbasson, C. M., & Nishikawa, Y. (2010). Cognitive behavioral group therapy for patients with co-existing social anxiety disorder and substance use disorders: A pilot study. Cognitive Therapy And Research, 34(1), 82–91. doi:10.1007/s10608-008-9216-8
   Web of Science ®Google Scholar
• *Cowart, M. J. W., & Ollendick, T. H. (2011). Attention training in socially anxious children: A multiple baseline design analysis. Journal of Anxiety Disorders, 25(7), 972–977. doi:10.1016/j.janxdis.2011.06.005
   PubMed Web of Science ®Google Scholar
• *Dalrymple, K. L., & Herbert, J. D. (2007). Acceptance and commitment therapy for generalized social anxiety disorder: A pilot study. Behavior Modification, 31(5), 543–568. doi:10.1177/0145445507302037
   PubMed Web of Science ®Google Scholar
• *Davidson, J., Yaryura-Tobias, J., DuPont, R., Stallings, L., Barbato, L. M., van der Hoop, R. G., & Li, D. (2004). Fluvoxamine-controlled release formulation for the treatment of generalized social anxiety disorder. Journal of Clinical Psychopharmacology, 24(2), 118–125. doi:10.1097/01.jcp.0000106222.36344.96
   PubMed Web of Science ®Google Scholar
• *Davidson, J. R. T. (2004). Use of Benzodiazepines in social anxiety disorder, generalized anxiety disorder, and posttraumatic stress disorder. Journal of Clinical Psychiatry, 65(5), 29–33.
   Google Scholar
• *De Menezes, G. B., Fontenelle, L. F., & Versiani, M. (2008). Gender effect on clinical features and drug treatment response in social anxiety disorder (social phobia). International Journal Of Psychiatry In Clinical Practice, 12(2), 151–155. doi:10.1080/13651500701568317
   PubMed Web of Science ®Google Scholar
• *Dear, B. F., Titov, N., Schwencke, G., Andrews, G., Johnston, L., Craske, M. G., & McEvoy, P. (2011). An open trial of a brief transdiagnostic internet treatment for anxiety and depression. Behaviour Research and Therapy, 49(12), 830–837. doi:10.1016/j.brat.2011.09.007
   PubMed Web of Science ®Google Scholar
• *Delsignore, A. (2008). Does prior psychotherapy experience affect the course of cognitive-behavioural group therapy for social anxiety disorder? The Canadian Journal Of Psychiatry, 53(8), 509–516.
   PubMed Web of Science ®Google Scholar
• *Dempsey, J. P., Randall, P. K., Thomas, S. E., Book, S. W., & Carrigan, M. H. (2009). Treatment of social anxiety with paroxetine: Mediation of changes in anxiety and depression symptoms. Comprehensive Psychiatry, 50(2), 135–141. doi:10.1016/j.comppsych.2008.06.009
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Lyles, C., & Crepaz N., TREND group. (2004). Improving the reporting of nonrandomized evaluations of behavioral and public health interventions: The TREND Statement. American Journal Public Health, 94, 361–366.
   PubMed Web of Science ®Google Scholar
• *Dogaheh, E. R., Mohammadkhani, P., & Dolatshahi, B. (2011). Comparison of group and individual cognitive-behavioral therapy in reducing fear of negative evaluation. Psychological Reports, 108(3), 955–962. doi:10.2466/02.21.pr0.108.3.955-962
   PubMed Web of Science ®Google Scholar
• *Eng, W., Coles, M. E., Heimberg, R. G., & Safren, S. A. (2001). Quality of life following cognitive behavioral treatment for social anxiety disorder: Preliminary findings. Depression and Anxiety, 13(4), 192–193. doi:10.1002/da.1037.abs
   PubMed Web of Science ®Google Scholar
• *Eng, W., Coles, M. E., Heimberg, R. G., & Safren, S. A. (2005). Domains of life satisfaction in social anxiety disorder: Relation to symptoms and response to cognitive-behavioral therapy. Journal of Anxiety Disorders, 19(2), 143–156. doi:10.1016/j.janxdis.2004.01.007
   PubMed Web of Science ®Google Scholar
• *Eng, W., Roth, D. A., & Heimberg, R. G. (2001). Cognitive behavioral therapy for social anxiety disorder. Journal of Cognitive Psychotherapy, 15(4), 311–319.
   Google Scholar
• *Erwin, B. A., Heimberg, R. G., Schneier, F. R., & Liebowitz, M. R. (2003). Anger experience and expression in social anxiety disorder: Pretreatment profile and predictors of attrition and response to cognitive-behavioral treatment. Behavior Therapy, 34(3), 331–350.
   Web of Science ®Google Scholar
• *Evans, K. C., Simon, N. M., Dougherty, D. D., Hoge, E. A., Worthington, J. J., Chow, C., … Rauch, S. L. (2009). A PET study of tiagabine treatment implicates ventral medial prefrontal cortex in generalized social anxiety disorder. Neuropsychopharmacology, 34(2), 390–398.
   PubMed Web of Science ®Google Scholar
• *Feeney, S. L. (2004). The cognitive-behavioral treatment of social phobia. Clinical Case Studies, 3(2), 124–146. doi:10.1177/1534650103259621
   Google Scholar
• *Feltner, D. E., Liu-Dumaw, M., Schweizer, E., & Bielski, R. (2011). Efficacy of pregabalin in generalized social anxiety disorder: Results of a double-blind, placebo-controlled, fixed-dose study. International Clinical Psychopharmacology, 26(4), 213–220. doi:10.1097/YIC.0b013e32834519bd
   PubMed Web of Science ®Google Scholar
• *Fisher, P. H., Masia-Warner, C., & Klein, R. G. (2004). Skills for social and academic success: A school-based intervention for social anxiety disorder in adolescents. Clinical Child and Family Psychology Review, 7(4), 241–249. doi:10.1007/s10567-004-6088-7
   PubMed Web of Science ®Google Scholar
• *Fogler, J., Tompson, M. C., Steketee, G., & Hofmann, S. G. (2007). Influence of expressed emotion and perceived criticism on cognitive-behavioral therapy for social phobia. Behaviour Research and Therapy, 45(2), 235–249. doi:10.1016/j.brat.2006.03.002
   PubMed Web of Science ®Google Scholar
• *Franklin, M. E., Feeny, N. C., Abramowitz, J. S., Zoellner, L. A., & Bux, D. A. (2001). Comprehensive cognitive behavior therapy: A multi-component treatment for generalized social phobia. Psicoterapia Cognitiva e Comportamentale, 7(3), 211–221.
   Google Scholar
• *Furmark, T., Appel, L., Henningsson, S., Åhs, F., Faria, V., Linnman, C., … Fredrikson, M. (2008). A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. The Journal of Neuroscience, 28(49), 13066–13074.
   PubMed Web of Science ®Google Scholar
• *Furmark, T., Appel, L., Michelgård, Å., Wahlstedt, K., Åhs, F., Zancan, S., … Fredrikson, M. (2005). Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo. Biological Psychiatry, 58(2), 132–142.
   PubMed Web of Science ®Google Scholar
• *Furmark, T., Carlbring, P., Hedman, E., Sonnenstein, A., Clevberger, P., Bohman, B., … Andersson, G. (2009). Guided and unguided self-help for social anxiety disorder: Randomised controlled trial. The British Journal of Psychiatry, 195(5), 440–447.
   PubMed Web of Science ®Google Scholar
• *Gallagher, H. M. (2002). A cognitive-behavioral group intervention for social phobia: Extension to a preadolescent sample. (62), ProQuest Information & Learning, US. Retrieved from http://ezproxy.gsu.edu:2048/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=psyh&AN=2002-95002-230&site=ehost-live
   Google Scholar
• *Gamer, J., Schmukle, S. C., Luka-Krausgrill, U., & Egloff, B. (2008). Examining the dynamics of the implicit and the explicit self-concept in social anxiety: Changes in the Implicit Association test-anxiety and the social phobia anxiety inventory following treatment. Journal of Personality Assessment, 90(5), 476–480. doi:10.1080/00223890802248786
   PubMed Web of Science ®Google Scholar
• *Garcia-Lopez, L.-J., Muela, J. M., Espinosa-Fernandez, L., & Diaz-Castela, M. (2009). Exploring the relevance of expressed emotion to the treatment of social anxiety disorder in adolescence. Journal of Adolescence, 32(6), 1371–1376. doi:10.1016/j.adolescence.2009.08.001
   PubMed Web of Science ®Google Scholar
• *García-López, L.-J., Olivares, J., Turner, S. M., Beidel, D. C., Albano, A. M., & Sánchez-Meca, J. (2002). Results at long-term among three psychological treatments for adolescents with generalized social phobia (II): Clinical significance and effect size. Psicología Conductual Revista Internacional de Psicología Clínica de la Salud, 10(2), 371–385.
   Google Scholar
• Gary, F. A. (2005). Stigma: Barrier to mental health care among ethnic minorities. Issues in Mental Health Nursing, 26, 979–999. doi:10.1080/01612840500280638
   PubMedGoogle Scholar
• *Gaudiano, B. A., & Herbert, J. D. (2003). Preliminary psychometric evaluation of a new self-efficacy scale and its relationship to treatment outcome in social anxiety disorder. Cognitive Therapy and Research, 27(5), 537–555. doi:10.1023/a:1026355004548
   Web of Science ®Google Scholar
• *Ginsburg, G. S., Kendall, P. C., Sakolsky, D., Compton, S. N., Piacentini, J., Albano, A. M., … March, J. (2011). Remission after acute treatment in children and adolescents with anxiety disorders: Findings from the CAMS. Journal of Consulting and Clinical Psychology, 79(6), 806–813.
   PubMed Web of Science ®Google Scholar
• Glasgow, R. E., & Emmons, K. M. (2007). How can we increase translation of research into practice? Types of evidence needed. Annual Review of Public Health, 28, 413–433.
   PubMed Web of Science ®Google Scholar
• Glasgow, R. E., Klesges, L. M., Dzewaltowski, D. A., Estabrooks, P. A., & Vogt, T. M. (2006). Evaluating the impact of health promotion programs: Using the RE-AIM framework to form summary measures for decision making involving complex issues. Health Education Research, 21, 688–694. doi:10.1093/her/cyl081
   PubMed Web of Science ®Google Scholar
• *Golden, A. (2011). Wrestling with the beaver: Embracing absurd exposure in the treatment of social anxiety disorder. The Behavior Therapist, 34(5), 87–90.
   Google Scholar
• *Goldin, P., Ramel, W., & Gross, J. (2009). Mindfulness meditation training and self-referential processing in social anxiety disorder: Behavioral and neural effects. Journal of Cognitive Psychotherapy, 23(3), 242–257. doi:10.1891/0889-8391.23.3.242
   PubMedGoogle Scholar
• *Goodwin, R. D., & Fitzgibborn, M. L. (2002). Social anxiety as a barrier to treatment for eating disorders. International Journal of Eating Disorders, 32(1), 103–106.
   PubMed Web of Science ®Google Scholar
• *Greist, J. H., Liu-Dumaw, M., Schweizer, E., & Feltner, D. (2011). Efficacy of pregabalin in preventing relapse in patients with generalized social anxiety disorder: Results of a double-blind, placebo-controlled 26-week study. International Clinical Psychopharmacology, 26(5), 243–251. doi:10.1097/YIC.0b013e3283491fd5
   PubMed Web of Science ®Google Scholar
• *Guastella, A. J., Howard, A. L., Dadds, M., Mitchell, P., & Carson, D. S. (2009). A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology, 34(6), 917–923. doi:10.1016/j.psyneuen.2009.01.005
   PubMed Web of Science ®Google Scholar
• *Guastella, A. J., Richardson, R., Lovibond, P. F., Rapee, R. M., Gaston, J. E., Mitchell, P., & Dadds, M. R. (2008). A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder. Biological Psychiatry, 63(6), 544–549. doi:10.1016/j.biopsych.2007.11.011
   PubMed Web of Science ®Google Scholar
• *Hall, S. S., Lightbody, A. A., McCarthy, B. E., Parker, K. J., & Reiss, A. L. (2011). Effects of intranasal oxytocin on social anxiety in males with fragile x syndrome. Psychoneuroendocrinology, 37, 509–518.
   Google Scholar
• *Harris, S. R., Kemmerling, R. L., & North, M. M. (2002). Brief virtual reality therapy for public speaking anxiety. CyberPsychology & Behavior, 5(6), 543–550. doi:10.1089/109493102321018187.
   PubMedGoogle Scholar
• *Haug, T. T., Blomhoff, S., & Hellstrom, K. (2003). The benefits of exposure therapy alone may last longer than sertraline alone or sertraline plus exposure therapy in social phobia. Evidence Based Mental Health, 182, 312–318.
   Google Scholar
• *Hayes, S. A., Hope, D. A., & Heimberg, R. G. (2008). The pattern of subjective anxiety during in-session exposures over the course of cognitive-behavioral therapy for clients with social anxiety. Behavior Therapy, 39(3), 286–299. doi:10.1016/j.beth.2007.09.001
   PubMed Web of Science ®Google Scholar
• *Hedman, E., Andersson, E., Ljótsson, B., Andersson, G., Rück, C., & Lindefors, N. (2011). Cost-effectiveness of Internet-based cognitive behavior therapy vs. cognitive behavioral group therapy for social anxiety disorder: Results from a randomized controlled trial. Behaviour Research and Therapy, 49(11), 729–736. doi:10.1016/j.brat.2011.07.009
   PubMed Web of Science ®Google Scholar
• *Hedman, E., Andersson, G., Ljótsson, B., Andersson, E., Rück, C., Mörtberg, E., & Lindefors, N. (2011). Internet-based cognitive behavior therapy vs. cognitive behavioral group therapy for social anxiety disorder: A randomized controlled non-inferiority trial. PLoS ONE, 6(3). doi:10.1371/journal.pone.0018001
   Web of Science ®Google Scholar
• *Heeren, A., Reese, H. E., McNally, R. J., & Philippot, P. (2011). Attention training toward and away from threat in social phobia: Effects on subjective, behavioral, and physiological measures of anxiety. Behaviour Research and Therapy, 50, 30–39.
   PubMedGoogle Scholar
• *Helgadóttir, F. D., Menzies, R. G., Onslow, M., Packman, A., & O'Brian, S. (2009). Online CBT II: A phase I trial of a standalone, online CBT treatment program for social anxiety in stuttering. Behaviour Change, 26(4), 254–270. doi:10.1375/bech.26.4.254
   Web of Science ®Google Scholar
• *Herbert, J. D., Gaudiano, B. A., Rheingold, A. A., Moitra, E., Myers, V. H., Dalrymple, K. L., & Brandsma, L. L. (2009). Cognitive behavior therapy for generalized social anxiety disorder in adolescents: A randomized controlled trial. Journal of Anxiety Disorders, 23(2), 167–177. doi:10.1016/j.janxdis.2008.06.004
   PubMed Web of Science ®Google Scholar
• *Herbert, J. D., Gaudiano, B. A., Rheingold, A. A., Myers, V. H., Dalrymple, K., & Nolan, E. M. (2005). Social skills training augments the effectiveness of cognitive behavioral group therapy for social anxiety disorder. Behavior Therapy, 36(2), 125–138. doi:10.1016/s0005-7894(05)80061-9
   Web of Science ®Google Scholar
• *Herbert, J. D., Rheingold, A. A., & Goldstein, S. G. (2002). Brief cognitive behavioral group therapy for social anxiety disorder. Cognitive and Behavioral Practice, 9(1), 1–8. doi:10.1016/s1077-7229(02)80033-5
   Google Scholar
• *Herbert, J. D., Rheingold, A. A., Gaudiano, B. A., & Myers, V. H. (2004). Standard versus extended cognitive behavior therapy for social anxiety disorder: A randomized-controlled trial. Behavioural and Cognitive Psychotherapy, 32(2), 131–147. doi:10.1017/s1352465804001171
   Web of Science ®Google Scholar
• *Hindo, C. S., & González-Prendes, A. A. (2011). One-session exposure treatment for social anxiety with specific fear of public speaking. Research on Social Work Practice, 21(5), 528–538. doi: 10.1177/1049731510393984
   Web of Science ®Google Scholar
• *Hoffart, A., Borge, F., Sexton, H., & Clark, D. M. (2009). Change processes in residential cognitive and interpersonal psychotherapy for social phobia: A process-outcome study. Behavior Therapy, 40(1), 10–22. doi:10.1016/j.beth.2007.12.003
   PubMed Web of Science ®Google Scholar
• *Hofmann, S. G. (2004). Cognitive mediation of treatment change in social phobia. Journal of Consulting and Clinical Psychology, 72(3), 392–399. doi:10.1037/0022-006x.72.3.392
   Web of Science ®Google Scholar
• *Hofmann, S. G., Moscovitch, D. A., Kim, H.-J., & Taylor, A. N. (2004). Changes in self-perception during treatment of social phobia. Journal of Consulting and Clinical Psychology, 72(4), 588–596. doi:10.1037/0022-006x.72.4.588
   PubMed Web of Science ®Google Scholar
• *Hood, S. D., Potokar, J. P., Davies, S. J. C., Hince, D. A., Morris, K., Seddon, K. M., … Argyropoulos, S. V. (2010). Dopaminergic challenges in social anxiety disorder: Evidence for dopamine D₃ desensitization following successful treatment with serotonergic antidepressants. Journal of Psychopharmacology, 24(5), 709–716.
   PubMed Web of Science ®Google Scholar
• *Hougaard, E., Madsen, S. S., Hansen, L. M., Jensen, M., Katborg, G. S., Morsaa, L., … Piet, J. (2008). A novel group therapeutic format in cognitive behavioral treatment for clients with social phobia in a training setting: A case study of one treatment group with nine clients. Pragmatic Case Studies in Psychotherapy, 4(4), 1–52.
   Google Scholar
• *Huppert, J. D., Strunk, D. R., Ledley, D. R., Davidson, J. T., & Foa, E. B. (2008). Generalized social anxiety disorder and avoidant personality disorder: Structural analysis and treatment outcome. Depression and Anxiety, 25(5), 441–448. doi:10.1002/da.20349
   PubMed Web of Science ®Google Scholar
• *Isolan, L., Pheula, G., Salum, G. J., Oswald, S., Rohde, L. A., & Manfro, G. G. (2007). An open-label trial of escitalopram in children and adolescents with social anxiety disorder. Journal of Child and Adolescent Psychopharmacology, 17(6), 751–760. doi:10.1089/cap.2007.0007
   PubMed Web of Science ®Google Scholar
• *Jazaieri, H., Goldin, P. R., Werner, K., Ziv, M., & Gross, J. J. (2012). A randomized trial of MBSR versus aerobic exercise for social anxiety disorder. Journal of Clinical Psychology, 68(7), 715–731. doi:10.1002/jclp.21863
   PubMed Web of Science ®Google Scholar
• *Karp, J., & Dugas, M. J. (2003). Stuck behind a wall of fear: How cognitive-behavior therapy helped one woman with social phobia. Clinical Case Studies, 2(3), 171–187. doi:10.1177/1534650103002003001
   Google Scholar
• *Kashdan, T. B., & Roberts, J. E. (2011). Comorbid social anxiety disorder in clients with depressive disorders: Predicting changes in depressive symptoms, therapeutic relationships, and focus of attention in group treatment. Behaviour Research and Therapy, 49(12), 875–884. doi:10.1016/j.brat.2011.10.002
   PubMed Web of Science ®Google Scholar
• *Kasper, S., Stein, D. J., Loft, H., & Nil, R. (2005). Escitalopram in the treatment of social anxiety disorder: Randomised, placebo-controlled, flexible-dosage study. British Journal of Psychiatry, 186(3), 222–226. doi: 10.1192/bjp.186.3.222
   PubMed Web of Science ®Google Scholar
• *Katerelos, M., Hawley, L. L., Antony, M. M., & McCabe, R. E. (2008). The exposure hierarchy as a measure of progress and efficacy in the treatment of social anxiety disorder. Behavior Modification, 32(4), 504–518. doi:10.1177/0145445507309302
   PubMed Web of Science ®Google Scholar
• *Kendall, P. C., Furr, J. M., & Podell, J. L. (2010). Child-focused treatment of anxiety. In J. R. Weisz & A. E. Kazdin (Eds.), Evidence-based psychotherapies for children and adolescents (2nd ed., pp. 45–60). New York, NY: Guilford Press.
   Google Scholar
• *Kim, H.Y., Lundh, L.-G., & Harvey, A. (2002). The enhancement of video feedback by cognitive preparation in the treatment of social anxiety: A single-session experiment. Journal of Behavior Therapy and Experimental Psychiatry, 33(1), 19–37. doi:10.1016/s0005-7916(02)00010-1
   PubMed Web of Science ®Google Scholar
• *Kim, K. L., Parr, A. F., & Alfano, C. A. (2011). Behavioral and cognitive behavioral treatments for social anxiety disorder in adolescents and young adults. In C. A. Alfano, & D. C. Beidel (Eds.), Social anxiety in adolescents and young adults: Translating developmental science into practice (pp. 245–264). Washington, DC: American Psychological Association.
   Google Scholar
• *Kinrys, G., Pollack, M. H., Simon, N. M., Worthington, J. J., Nardi, A. E., & Versiani, M. (2003). Valproic acid for the treatment of social anxiety disorder. International Clinical Psychopharmacology, 18(3), 169–172. doi:10.1097/00004850-200305000-00008
   PubMed Web of Science ®Google Scholar
• *Klinger, E., Bouchard, S., Légeron, P., Roy, S., Lauer, F., Chemin, I., & Nugues, P. (2005). Virtual reality therapy versus cognitive behavior therapy for social phobia: A preliminary controlled study. CyberPsychology & Behavior, 8(1), 76–88. doi:10.1089/cpb.2005.8.76.
   PubMedGoogle Scholar
• *Klinger, E., Chemin, I., Légeron, P., Roy, S., Lauer, F., & Nugues, P. (2003). Designing virtual worlds to treat social phobia. Annual Review of CyberTherapy and Telemedicine, 1, 111–119.
   Google Scholar
• *Knijnik, D. Z., Blanco, C., Salum, G. A., Moraes, C. U., Mombach, C., Almeida, E., … Eizirik, C. L. (2008). A pilot study of clonazepam versus psychodynamic group therapy plus clonazepam in the treatment of generalized social anxiety disorder. European Psychiatry, 23(8), 567–574.
   PubMed Web of Science ®Google Scholar
• *Kobak, K. A., Greist, J. H., Jefferson, J. W., & Katzelnick, D. J. (2002). Fluoxetine in social phobia: A double-blind, placebo-controlled pilot study. Journal of Clinical Psychopharmacology, 22(3), 257–262. doi:10.1097/00004714-200206000-00005
   PubMed Web of Science ®Google Scholar
• *Kobak, K. A., Taylor, L. v. H., Warner, G., & Futterer, R. (2005). St. John's Wort versus placebo in social phobia: Results from a placebo-controlled pilot study. Journal of Clinical Psychopharmacology, 25(1), 51–58. doi:10.1097/01.jcp.0000150227.61501.00
   PubMed Web of Science ®Google Scholar
• *Kocovski, N. L., Fleming, J. E., & Rector, N. A. (2009). Mindfulness and acceptance-based group therapy for social anxiety disorder: An open trial. Cognitive and Behavioral Practice, 16(3), 276–289. doi:10.1016/j.cbpra.2008.12.004
   Web of Science ®Google Scholar
• *Koszycki, D., Benger, M., Shlik, J., & Bradwejn, J. (2007). Randomized trial of a meditation-based stress reduction program and cognitive behavior therapy in generalized social anxiety disorder. Behaviour Research and Therapy, 45(10), 2518–2526. doi:10.1016/j.brat.2007.04.011
   PubMed Web of Science ®Google Scholar
• *Lader, M., Stender, K., Bürger, V., & Nil, R. (2004). Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: Randomised, double-blind, placebo-controlled, fixed-dose study. Depression and Anxiety, 19(4), 241–248. doi:10.1002/da.20014
   PubMed Web of Science ®Google Scholar
• *Laposa, J. M., & Rector, N. A. (2011). A prospective examination of predictors of post-event processing following videotaped exposures in group cognitive behavioural therapy for individuals with social phobia. Journal of Anxiety Disorders, 25(4), 568–573. doi:10.1016/j.janxdis.2011.01.004
   PubMed Web of Science ®Google Scholar
• *Ledley, D. R., Heimberg, R. G., Hope, D. A., Hayes, S. A., Zaider, T. I., Dyke, M. V., … Fresco, D. M. (2009). Efficacy of a manualized and workbook-driven individual treatment for social anxiety disorder. Behavior Therapy, 40(4), 414–424.
   PubMed Web of Science ®Google Scholar
• *Ledley, D. R., Huppert, J. D., Foa, E. B., Davidson, J. R. T., Keefe, F. J., & Potts, N. L. S. (2005). Impact of depressive symptoms on the treatment of generalized social anxiety disorder. Depression and Anxiety, 22(4), 161–167. doi:10.1002/da.20121
   PubMed Web of Science ®Google Scholar
• *Lepola, U., Bergholdt, B., Lambert, J. S., Davy, K. L., & Ruggiero, L. (2004). Controlled-release paroxetine in the treatment of patients with social anxiety disorder. Journal of Clinical Psychiatry, 65(2), 222–229.
   PubMed Web of Science ®Google Scholar
• *Liappas, J., Paparrigopoulos, T., Tzavellas, E., & Christodoulou, G. (2003). Alcohol detoxification and social anxiety symptoms: A preliminary study of the impact of mirtazapine administration. Journal of Affective Disorders, 76(1–3), 279–284. doi:10.1016/s0165-0327(02)00094-0
   PubMed Web of Science ®Google Scholar
• *Liebowitz, M. R., DeMartinis, N. A., Weihs, K., Londborg, P. D., Smith, W. T., Chung, H., … Clary, C. M. (2003). Efficacy of sertraline in severe generalized social anxiety disorder: Results of a double-blind, placebo-controlled study. Journal of Clinical Psychiatry, 64(7), 785–792.
   PubMed Web of Science ®Google Scholar
• *Liebowitz, M. R., Gelenberg, A. J., & Munjack, D. (2005). Venlafaxine extended release vs. placebo and paroxetine in social anxiety disorder. Archives of General Psychiatry, 62(2), 190–198. doi:10.1001/archpsyc.62.2.190
   PubMed Web of Science ®Google Scholar
• *Liebowitz, M. R., Mangano, R. M., Bradwejn, J., & Asnis, G. (2005). A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder. Journal of Clinical Psychiatry, 66(2), 238–247. doi:10.4088/JCP.v66n0213
   PubMed Web of Science ®Google Scholar
• *Liebowitz, M. R., Stein, M. B., Tancer, M., Carpenter, D., Oakes, R., & Pitts, C. D. (2002). A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in treatment of generalized social anxiety disorder. Journal of Clinical Psychiatry, 63(1), 66–74.
   PubMed Web of Science ®Google Scholar
• Lindner, P., Martell, P., Bergström, J., Andersson, G., & Carlbring, P. (2013). Clinical validation of a nonheteronormative version of the Social Interaction Anxiety Scale (SIAS). Health and Quality of Life Outcomes, 11, 209. doi:10.1186/1477-7525-11-209
   PubMed Web of Science ®Google Scholar
• *Lipsitz, J. D., Gur, M., Vermes, D., Petkova, E., Cheng, J., Miller, N., … Fyer, A. J. (2008). A randomized trial of interpersonal therapy versus supportive therapy for social anxiety disorder. Depression and Anxiety, 25(6), 542–553.
   PubMed Web of Science ®Google Scholar
• *Lundh, L.-G., & Öst, L.-G. (2001). Attentional bias, self-consciousness and perfectionism in social phobia before and after cognitive-behaviour therapy. Scandinavian Journal of Behaviour Therapy, 30(1), 4–16. doi:10.1080/028457101300140428
   Google Scholar
• *Mall, A. K., Mehl, A., Kiko, S., Kleindienst, N., Salize, H.-J., Hermann, C., … Steil, R. (2011). Evaluation of a DVD-based self-help program in highly socially anxious individuals – pilot study. Behavior Therapy, 42(3), 439–448.
   PubMed Web of Science ®Google Scholar
• *March, J. S., Entusah, A. R., Rynn, M., Albano, A. M., & Tourian, K. A. (2007). A randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder. Biological Psychiatry, 62(10), 1149–1154. doi:10.1016/j.biopsych.2007.02.025
   PubMed Web of Science ®Google Scholar
• *Marom, S., Gilboa-Schechtman, E., Aderka, I. M., Weizman, A., & Hermesh, H. (2009). Impact of depression on treatment effectiveness and gains maintenance in social phobia: A naturalistic study of cognitive behavior group therapy. Depression and Anxiety, 26(3), 289–300. doi:10.1002/da.20390
   PubMed Web of Science ®Google Scholar
• *Masia, C. L., Klein, R. G., Storch, E. A., & Corda, B. (2001). School-based behavioral treatment for social anxiety disorder in adolescents: Results of a pilot study. Journal of the American Academy of Child & Adolescent Psychiatry, 40(7), 780–786. doi:10.1097/00004583-200107000-00012
   PubMed Web of Science ®Google Scholar
• *Masia-Warner, C., Fisher, P. H., Ludwig, K. A., Rialon, R., & Ryan, J. L. (2011). Adapting treatment of social anxiety disorder for delivery in schools: A school-based intervention for adolescents. In C. A. Alfano, & D. C. Beidel (Eds.), Social anxiety in adolescents and young adults: Translating developmental science into practice (pp. 281–296). Washington, DC: American Psychological Association.
   Google Scholar
• *Masia-Warner, C., Klein, R. G., Dent, H. C., Fisher, P. H., Alvir, J., Albano, A. M., & Guardino, M. (2005). School-based intervention for adolescents with social anxiety disorder: Results of a controlled study. Journal of Abnormal Child Psychology: An official publication of the International Society for Research in Child and Adolescent Psychopathology, 33(6), 707–722. doi:10.1007/s10802-005-7649-z
   Web of Science ®Google Scholar
• *Mayers, A. G., & Baldwin, D. (2003). Drug treatment of social anxiety disorder. Current Medical Literature: Psychiatry, 14(3), 55–60.
   Google Scholar
• *McEvoy, P. M., Mahoney, A., Perini, S. J., & Kingsep, P. (2009). Changes in post-event processing and metacognitions during cognitive behavioral group therapy for social phobia. Journal of Anxiety Disorders, 23(5), 617–623. doi:10.1016/j.janxdis.2009.01.011
   PubMed Web of Science ®Google Scholar
• *McEvoy, P. M., & Perini, S. J. (2009). Cognitive behavioral group therapy for social phobia with or without attention training: A controlled trial. Journal of Anxiety Disorders, 23(4), 519–528. doi:10.1016/j.janxdis.2008.10.008
   PubMed Web of Science ®Google Scholar
• *Miller, V. A., & Feeny, N. C. (2003). Modification of cognitive-behavioral techniques in the treatment of a five year-old girl with social phobia. Journal of Contemporary Psychotherapy, 33(4), 303–319. doi:10.1023/b:jocp.0000004501.18852.40
   Google Scholar
• *Miskovic, V., Moscovitch, D. A., Santesso, D. L., McCabe, R. E., Antony, M. M., & Schmidt, L. A. (2011). Changes in EEG cross-frequency coupling during cognitive behavioral therapy for social anxiety disorder. Psychological Science, 22(4), 507–516. doi:10.1177/0956797611400914
   PubMed Web of Science ®Google Scholar
• Moher, D., Schulz, K. F., & Altman, D. G. (2001). The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials. Annals of Internal Medicine, 134, 657–662. doi:10.7326/0003-4819-134-8-200104170-00011
   PubMed Web of Science ®Google Scholar
• Mook, D. G. (1983). In defense of external invalidity. American Psychologist, 38, 379–387. doi:10.1037/0003-066X.38.4.379
   Web of Science ®Google Scholar
• *Morissette, S. B., Spiegel, D. A., & Barlow, D. H. (2008). Combining exposure and pharmacotherapy in the treatment of social anxiety disorder: A preliminary study of state dependent learning. Journal of Psychopathology and Behavioral Assessment, 30(3), 211–219. doi:10.1007/s10862-007-9061-
   Web of Science ®Google Scholar
• *Mörtberg, E., Berglund, G., & Sundin, Ö. (2005). Intensive cognitive behavioural group treatment for social phobia: A pilot study. Cognitive Behaviour Therapy, 34(1), 41–49. doi:10.1080/16506070510010657
   PubMedGoogle Scholar
• *Mörtberg, E., Clark, D. M., Sundin, Ö., & Wistedt, A. Å. (2007). Intensive group cognitive treatment and individual cognitive therapy vs. treatment as usual in social phobia: A randomized controlled trial. Acta Psychiatrica Scandinavica, 115(2), 142–154. doi:10.1111/j.1600-0447.2006.00839.x
   PubMed Web of Science ®Google Scholar
• *Moscovitch, D. A., Hofmann, S. G., Suvak, M. K., & In-Albon, T. (2005). Mediation of changes in anxiety and depression during treatment of social phobia. Journal of Consulting and Clinical Psychology, 73(5), 945–952. doi:10.1037/0022-006x.73.5.945
   PubMed Web of Science ®Google Scholar
• *Moscovitch, D. A., Santesso, D. L., Miskovic, V., McCabe, R. E., Antony, M. M., & Schmidt, L. A. (2011). Frontal EEG asymmetry and symptom response to cognitive behavioral therapy in patients with social anxiety disorder. Biological Psychology, 87(3), 379–385. doi:10.1016/j.biopsycho.2011.04.009
   PubMed Web of Science ®Google Scholar
• *Muehlbacher, M., Nickel, M. K., Nickel, C., Kettler, C., Lahmann, C., Pedrosa Gil, F., … Egger, C. (2005). Mirtazapine treatment of social phobia in women: A randomized, double-blind, placebo-controlled study. Journal of Clinical Psychopharmacology, 25(6), 580–583.
   PubMed Web of Science ®Google Scholar
• *Nagata, T., Oshima, J., Wada, A., Yamada, H., Iketani, T., & Kiriike, N. (2003). Open trial of milnacipran for Taijin-Kyofusho in Japanese patients with social anxiety disorder. International Journal of Psychiatry in Clinical Practice, 7(2), 107–112.
   Web of Science ®Google Scholar
• Neal, A. M., & Turner, S. M. (1991). Anxiety disorder research with African Americans: Current status. Psychological Bulletin, 109, 400–410.
   PubMed Web of Science ®Google Scholar
• *Nelson, E. A. (2011). Exposure to the cost of feared outcomes in social anxiety: A comparison of cognitive and behavioral approaches. (71), ProQuest Information & Learning, US. Retrieved from http://ezproxy.gsu.edu:2048/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=psyh&AN=2011-99120-174&site=ehost-live Available from EBSCOhost psyh database
   Google Scholar
• *Nilsson, J.-E., Lundh, L.-G., Faghihi, S., & Roth-Andersson, G. (2011). The enhancement of beneficial effects following audio feedback by cognitive preparation in the treatment of social anxiety: A single-session experiment. Journal of Behavior Therapy and Experimental Psychiatry, 42(4), 497–503. doi:10.1016/j.jbtep.2011.05.004
   PubMed Web of Science ®Google Scholar
• *Nordgreen, T., Havik, O. E., Öst, L. G., Furmark, T., Carlbring, P., & Andersson, G. (2011). Outcome predictors in guided and unguided self-help for social anxiety disorder. Behaviour Research and Therapy, 50, 13–21.
   PubMedGoogle Scholar
• *Nortje, C., Posthumus, T., & Möller, A. T. (2008). Comparison of integrated cognitive restructuring plus exposure with exposure alone in group treatment of generalised social anxiety disorder. South African Journal of Psychology, 38(4), 647–658.
   Web of Science ®Google Scholar
• *Olivares, J., Garcia-Lopez, L.-J., Beidel, D. C., Turner, S. M., Albano, A. M., & Hidalgo, M.-D. (2002). Results at long-term among three psychological treatments for adolescents with generalized social phobia (I): Statistical significance. Psicología Conductual Revista Internacional de Psicología Clínica de la Salud, 10(1), 147–164.
   Google Scholar
• *Olivares-Olivares, P. J., Rosa-Alcázar, A. I., & Olivares-Rodríguez, J. (2008). Does individual attention improve the effect of group treatment of adolescents with social phobia? International Journal of Clinical And Health Psychology, 8(2), 465–481.
   Web of Science ®Google Scholar
• *Oosterbaan, D. B., van Balkom, A. J. L. M., Spinhoven, P., de Meij, T. G. J., & van Dyck, R. (2002). The influence on treatment gain of comorbid avoidant personality disorder in patients with social phobia. Journal of Nervous and Mental Disease, 190(1), 41–43. doi:10.1097/00005053-200201000-00010
   PubMed Web of Science ®Google Scholar
• Ost, L. G. (2008). Efficacy of the third wave of behavioral therapies: A systematic review and meta-analysis. Behaviour Research and Therapy, 46(3), 296–321.
   PubMed Web of Science ®Google Scholar
• Osterling, K.L., & Austin, M. J. (2008). The dissemination and utilization of research for promoting evidence-based practice. Journal of Evidence-Based Social Work, 5, 295–319.
   PubMedGoogle Scholar
• *Pande, A. C., Feltner, D. E., Jefferson, J. W., Davidson, J. R. T., Pollack, M., Stein, M. B., … Werth, J. L. (2004). Efficacy of the novel anxiolytic Pregabalin in social anxiety disorder: A placebo-controlled, multicenter study. Journal of Clinical Psychopharmacology, 24(2), 141–149.
   PubMed Web of Science ®Google Scholar
• *Pishyar, R., Harris, L. M., & Menzies, R. G. (2008). Responsiveness of measures of attentional bias to clinical change in social phobia. Cognition and Emotion, 22(7), 1209–1227. doi:10.1080/02699930701686008
   Web of Science ®Google Scholar
• *Pollack, M. H., Jensen, J. E., Simon, N. M., Kaufman, R. E., & Renshaw, P. F. (2008). High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: Response to treatment with levetiracetam. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 32(3), 739–743. doi:10.1016/j.pnpbp.2007.11.023
   PubMed Web of Science ®Google Scholar
• *Powers, M. B., Capozzoli, M., Handelsman, P., & Smits, J. A. J. (2010). Comparison between psychosocial and pharmacological treatments. In S. G. Hofmann & P. M. DiBartolo (Eds.), Social anxiety: Clinical, developmental, and social perspectives (2nd ed., pp. 555–575). San Diego, CA: Elsevier Academic Press.
   Google Scholar
• *Price, M., & Anderson, P. L. (2010). The impact of cognitive behavioral therapy on post event processing among those with social anxiety disorder. Behaviour Research and Therapy, 49, 132–137.
   Google Scholar
• *Price, M., & Anderson, P. L. (2011a). Latent growth curve analysis of fear during a speech task before and after treatment for social phobia. Behaviour Research and Therapy, 49(11), 763–770. doi:10.1016/j.brat.2011.08.004
   PubMed Web of Science ®Google Scholar
• *Price, M., & Anderson, P. L. (2011b). Outcome expectancy as a predictor of treatment response in cognitive behavioral therapy for public speaking fears within social anxiety disorder. Psychotherapy, 49, 173–179.
   Google Scholar
• *Price, M., Mehta, N., Tone, E. B., & Anderson, P. L. (2011). Does engagement with exposure yield better outcomes? Components of presence as a predictor of treatment response for virtual reality exposure therapy for social phobia. Journal of Anxiety Disorders, 25(6), 763–770. doi:10.1016/j.janxdis.2011.03.004
   PubMed Web of Science ®Google Scholar
• *Proudfoot, J., Goldberg, D., Mann, A., Everitt, B., Marks, I., & Gray, J. A. (2003). Computerized, interactive, multimedia cognitive-behavioural program for anxiety and depression in general practice. Psychological Medicine: A Journal of Research in Psychiatry and the Allied Sciences, 33(2), 217–227. doi:10.1017/s0033291702007225
   Web of Science ®Google Scholar
• *Randall, C. L., Johnson, M. R., Thevos, A. K., Sonne, S. C., Thomas, S. E., Willard, S. L., … Davidson, J. R. (2001). Paroxetine for social anxiety and alcohol use in dual-diagnosed patients. Depression and Anxiety, 14(4), 255–262.
   PubMed Web of Science ®Google Scholar
• *Rapee, R. M., Abbott, M. J., Baillie, A. J., & Gaston, J. E. (2007). Treatment of social phobia through pure self-help and therapist-augmented self-help. The British Journal of Psychiatry, 191(3), 246–252. doi:10.1192/bjp.bp.106.028167
   PubMed Web of Science ®Google Scholar
• *Rapee, R. M., Gaston, J. E., & Abbott, M. J. (2009). Testing the efficacy of theoretically derived improvements in the treatment of social phobia. Journal Of Consulting And Clinical Psychology, 77(2), 317–327. doi:10.1037/a0014800
   PubMed Web of Science ®Google Scholar
• *Ravindran, L. N., & Stein, M. B. (2011). Pharmacotherapy for social anxiety disorder in adolescents and young adults. In C. A. Alfano & D. C. Beidel (Eds.), Social anxiety in adolescents and young adults: Translating developmental science into practice (pp. 265–279). Washington, DC: American Psychological Association.
   Google Scholar
• *Rickels, K., Mangano, R., & Khan, A. (2004). A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder. Journal of Clinical Psychopharmacology, 24(5), 488–496. doi:10.1097/01.jcp.0000138764.31106.60
   PubMed Web of Science ®Google Scholar
• *Rosser, S., Erskine, A., & Crino, R. (2004). Pre-existing antidepressants and the outcome of group cognitive behaviour therapy for social phobia. Australian and New Zealand Journal of Psychiatry, 38(4), 233–239. doi:10.1111/j.1440-1614.2004.01345.x
   PubMed Web of Science ®Google Scholar
• *Rosser, S., Issakidis, C., & Peters, L. (2003). Perfectionism and social phobia: Relationship between the constructs and impact on cognitive behavior therapy. Cognitive Therapy & Research, 27(2), 143–151.
   Web of Science ®Google Scholar
• *Roy-Byrne, P., Craske, M. G., Sullivan, G., Rose, R. D., Edlund, M. J., Lang, A. J., … Stein, M. B. (2010). Delivery of evidence-based treatment for multiple anxiety disorders in primary care: A randomized controlled trial. JAMA: Journal Of The American Medical Association, 303(19), 1921–1928.
   PubMed Web of Science ®Google Scholar
• *Scharfstein, L. A., Beidel, D. C., Finnell, L. R., Distler, A., & Carter, N. T. (2011). Do pharmacological and behavioral interventions differentially affect treatment outcome for children with social phobia? Behavior Modification, 35(5), 451–467. doi:10.1177/0145445511408590
   PubMed Web of Science ®Google Scholar
• *Schmidt, N. B., Richey, J. A., Buckner, J. D., & Timpano, K. R. (2009). Attention training for generalized social anxiety disorder. Journal Of Abnormal Psychology, 118(1), 5–14. doi:10.1037/a0013643
   PubMed Web of Science ®Google Scholar
• *Schneier, F. R., Blanco, C., Campeas, R., Lewis-Fernandez, R., Shu-Hsing Lin, R., Marshall, R., … Liebowitz, M. R. (2003). Citalopram treatment of social anxiety disorder with comorbid major depression. Depression & Anxiety, 17(4), 191–196.
   PubMed Web of Science ®Google Scholar
• *Schneier, F. R., Pomplun, M., Sy, M., & Hirsch, J. (2011). Neural response to eye contact and paroxetine treatment in generalized social anxiety disorder. Psychiatry Research: Neuroimaging, 194(3), 271–278. doi:10.1016/j.pscychresns.2011.08.006
   PubMed Web of Science ®Google Scholar
• *Schutters, S. I. J., Van Megen, H. J.G. M., Van Veen, J. F., Denys, D. P., & Westenberg, H. M. (2010). Mirtazapine in generalized social anxiety disorder: A randomized, double-blind, placebo-controlled study. International Clinical Psychopharmacology, 25(5), 302–304. doi:10.1097/YIC.0b013e32833a4d71
   PubMed Web of Science ®Google Scholar
• *Schutters, S. I. J., Van Megen, H. J. G. M., Van Veen, J. F., Schruers, K. R. J., & Westenberg, H. G. M. (2011). Paroxetine augmentation in patients with generalised social anxiety disorder, non-responsive to mirtazapine or placebo. Human Psychopharmacology: Clinical and Experimental, 26(1), 72–76. doi:10.1002/hup.1165
   PubMed Web of Science ®Google Scholar
• *Seedat, S., & Stein, M. B. (2004). Double-blind, placebo-controlled assessment of combined clonazepam with paroxetine compared with paroxetine monotherapy for generalized social anxiety disorder. Journal of Clinical Psychiatry, 65(2), 244–248.
   PubMed Web of Science ®Google Scholar
• *Shorey, R. C., & Stuart, G. L. (2012). Manualized cognitive-behavioral treatment of social anxiety disorder: A case study. Clinical Case Studies, 11(1), 35–47. doi:10.1177/1534650112438462
   PubMed Web of Science ®Google Scholar
• *Silverman, W. K. (2003). Using CBT in the treatment of social phobia, separation of anxiety and GAD. Psychiatric Times, 20(9), 60–62.
   Google Scholar
• *Simon, N. M., Sharma, S. G., Worthington, J. J., Marzol, P. C., & Pollack, M. H. (2001). Citalopram for social phobia: A clinical case series. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 25(7), 1469–1474. doi:10.1016/s0278-5846(01)00189-0
   PubMed Web of Science ®Google Scholar
• *Simon, N. M., Worthington, J. J., Doyle, A. C., Hoge, E. A., Kinrys, G., Fischmann, D., … Pollack, M. H. (2004). An open-label study of Levetiracetam for the treatment of social anxiety disorder. Journal of Clinical Psychiatry, 65(9), 1219–1222.
   PubMed Web of Science ®Google Scholar
• *Smits, J. J., Minhajuddin, A., & Jarrett, R. B. (2009). Cognitive therapy for depressed adults with comorbid social phobia. Journal of Affective Disorders, 114(1-3), 271–278. doi:10.1016/j.jad.2008.08.008
   PubMed Web of Science ®Google Scholar
• *Stangier, U., Schramm, E., Heidenreich, T., Berger, M., & Clark, D. M. (2011). Cognitive therapy vs interpersonal psychotherapy in social anxiety disorder: A randomized controlled trial. Archives of General Psychiatry, 68(7), 692–700. doi:10.1001/archgenpsychiatry.2011.67
   PubMed Web of Science ®Google Scholar
• *Stein, D. J., Cameron, A., Amrein, R., Mongomery, S. A., & Moclobemide Social Phobia Clinical Study, G. (2002). Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder. International Clinical Psychopharmacology, 17(4), 161–170. doi:10.1097/00004850-200207000-00002
   PubMed Web of Science ®Google Scholar
• *Stein, D. J., Kasper, S., Andersen, E. W., Nil, R., & Lader, M. (2004). Escitalopram in the treatment of social anxiety disorder: Analysis of efficacy for different clinical subgroups and symptom dimensions. Depression and Anxiety, 20(4), 175–181. doi:10.1002/da.20043
   PubMed Web of Science ®Google Scholar
• *Stein, D. J., Stein, M. B., Goodwin, W., Kumar, R., & Hunter, B. (2001). The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder. Psychopharmacology, 158(3), 267–272. doi:10.1007/s002130100880
   PubMed Web of Science ®Google Scholar
• *Stein, D. J., Stein, M. B., Pitts, C. D., Kumar, R., & Hunter, B. (2002). Predictors of response to pharmacotherapy in social anxiety disorder: An analysis of 3 placebo-controlled paroxetine trials. Journal of Clinical Psychiatry, 63(2), 152–155.
   PubMed Web of Science ®Google Scholar
• *Stein, D. J., Versiani, M., Hair, T., & Kumar, R. (2002). Efficacy of paroxetine for relapse prevention in social anxiety disorder. Archives of General Psychiatry, 59(12), 1111–1118. doi:10.1001/archpsyc.59.12.1111
   PubMed Web of Science ®Google Scholar
• *Stein, D. J., Westenberg, H. G. M., Yang, H., Li, D., & Barbato, L. M. (2003). Fluvoxamine CR in the long-term treatment of social anxiety disorder: The 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial. International Journal of Neuropsychopharmacology, 6(4), 317–323. doi:10.1017/s146114570300364x
   PubMed Web of Science ®Google Scholar
• *Stein, M. B., Pollack, M. H., Bystritsky, A., Kelsey, J. E., & Mangano, R. M. (2005). Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: A 6-month randomized controlled trial. Psychopharmacology, 177(3), 280–288. doi:10.1007/s00213-004-1957-9
   PubMed Web of Science ®Google Scholar
• *Stein, M. B., Sareen, J., Hami, S., & Chao, J. (2001). Pindolol potentiation of paroxetine for generalized social phobia: A double-blind, placebo-controlled, crossover study. The American Journal of Psychiatry, 158(10), 1725–1727. doi:10.1176/appi.ajp.158.10.1725
   PubMed Web of Science ®Google Scholar
• *Stern, R. G., Petti, T. A., Bopp, K., & Tobia, A. (2009). Aripiprazole for the treatment of schizophrenia with co-occurring social anxiety: An open-label cross-taper study. Journal of Clinical Psychopharmacology, 29(3), 206–209. doi:10.1097/JCP.0b013e3181a48e12
   PubMed Web of Science ®Google Scholar
• *Thomas, S. E., Randall, P. K., Book, S. W., & Randall, C. L. (2008). The complex relationship between co-occurring social anxiety and alcohol use disorders: What effect does treating social anxiety have on drinking? Alcoholism: Clinical and Experimental Research, 32(1), 77–84. doi:10.1111/j.1530-0277.2007.00546.x
   PubMed Web of Science ®Google Scholar
• *Tillfors, M., Andersson, G., Ekselius, L., Furmark, T., Lewenhaupt, S., Karlsson, A., & Carlbring, P. (2011). A randomized trial of internet-delivered treatment for social anxiety disorder in high school students. Cognitive Behaviour Therapy, 40(2), 147–157. doi:10.1080/16506073.2011.555486
   PubMedGoogle Scholar
• *Tillfors, M., Carlbring, P., Furmark, T., Lewenhaupt, S., Spak, M., Eriksson, A., … Andersson, G. (2008). Treating university students with social phobia and public speaking fears: Internet delivered self-help with or without live group exposure sessions. Depression and Anxiety, 25(8), 708–717.
   PubMed Web of Science ®Google Scholar
• *Titov, N., Andrews, G., Choi, I., Schwencke, G., & Johnston, L. (2009). Randomized controlled trial of web-based treatment of social phobia without clinician guidance. Australian and New Zealand Journal of Psychiatry, 43(10), 913–919. doi:10.1080/00048670903179160
   Web of Science ®Google Scholar
• *Titov, N., Andrews, G., Johnston, L., Robinson, E., & Spence, J. (2010). Transdiagnostic Internet treatment for anxiety disorders: A randomized controlled trial. Behaviour Research and Therapy, 48(9), 890–899. doi:10.1016/j.brat.2010.05.014
   PubMed Web of Science ®Google Scholar
• *Titov, N., Andrews, G., Schwencke, G., Solley, K., Johnston, L., & Robinson, E. (2009). An RCT comparing effect of two types of support on severity of symptoms for people completing internet-based cognitive behaviour therapy for social phobia. Australian and New Zealand Journal of Psychiatry, 43(10), 920–926. doi:10.1080/00048670903179228
   Web of Science ®Google Scholar
• *Titov, N., Dear, B. F., Schwencke, G., Andrews, G., Johnston, L., Craske, M. G., & McEvoy, P. (2011). Transdiagnostic internet treatment for anxiety and depression: A randomised controlled trial. Behaviour Research and Therapy, 49(8), 441–452. doi:10.1016/j.brat.2011.03.007
   PubMed Web of Science ®Google Scholar
• *Titov, N., Gibson, M., Andrews, G., & McEvoy, P. (2009). Internet treatment for social phobia reduces comorbidity. Australian and New Zealand Journal of Psychiatry, 43, 754–759.
   Google Scholar
• *Turner, J. S., & Leach, D. J. (2009). Brief behavioural activation treatment of chronic anxiety in an older adult. Behaviour Change, 26(3), 214–222. doi:10.1375/bech.26.3.214
   Web of Science ®Google Scholar
• *Turner, R., Hoppitt, L., Hodgekins, J., Wilkinson, J., Mackintosh, B., & Fowler, D. (2011). Cognitive bias modification in the treatment of social anxiety in early psychosis: A single case series. Behavioural and Cognitive Psychotherapy, 39(3), 341–347. doi:10.1017/s1352465810000706
   PubMed Web of Science ®Google Scholar
• *Valentiner, D. P., Skowronski, J. J., McGrath, P. B., Smith, S. A., & Renner, K. A. (2011). Self-verification and social anxiety: Preference for negative social feedback and low social self-esteem. Behavioural and Cognitive Psychotherapy, 39(5), 601–617. doi: 10.1017/s1352465811000300
   PubMed Web of Science ®Google Scholar
• *Van Ameringen, M., Mancini, C., Pipe, B., Oakman, J., & Bennett, M. (2004). An open trial of topiramate in the treatment of generalized social phobia. Journal of Clinical Psychiatry, 65(12), 1674–1678.
   PubMed Web of Science ®Google Scholar
• *Vasile, R. G., Bruce, S. E., Goisman, R. M., Pagano, M., & Keller, M. B. (2005). Results of a naturalistic longitudinal study of benzodiazepine and SSRI use in the treatment of generalized anxiety disorder and social phobia. Depression and Anxiety, 22(2), 59–67. doi:10.1002/da.20089
   PubMed Web of Science ®Google Scholar
• *Wagner, K. D., Berard, R., Stein, M. B., Wetherhold, E., Carpenter, D. J., Perera, P., … Machin, A. (2004). A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder. Archives of General Psychiatry, 61(11), 1153–1162.
   PubMed Web of Science ®Google Scholar
• *Walsh, K., & Hope, D. A. (2010). LGB-affirmative cognitive behavioral treatment for social anxiety: A case study applying evidence-based practice principles. Cognitive and Behavioral Practice, 17(1), 56–65. doi:10.1016/j.cbpra.2009.04.007
   Web of Science ®Google Scholar
• *Watanabe, N., Furukawa, T. A., Chen, J., Kinoshita, Y., Nakano, Y., Ogawa, S., … Noda, Y. (2010). Change in quality of life and their predictors in the long-term follow-up after group cognitive behavioral therapy for social anxiety disorder: A prospective cohort study. BMC Psychiatry, 10, 81.
   Google Scholar
• *Weiss, B. J., Singh, J. S., & Hope, D. A. (2011). Cognitive-behavioral therapy for immigrants presenting with social anxiety disorder: Two case studies. Clinical Case Studies, 10(4), 324–342. doi:10.1177/1534650111420706
   PubMedGoogle Scholar
• *Wells, A., & Papageourgiou, C. (2001). Brief cognitive therapy for social phobia: A case series. Behaviour Research and Therapy, 39(6), 713–720. doi:10.1016/s0005-7967(00)00036-x
   PubMed Web of Science ®Google Scholar
• *Westenberg, H. G. M., Stein, D. J., Yang, H., Li, D., & Barbato, L. M. (2004). A double-blind placebo-controlled study of controlled release fluvoxamine for the treatment of generalized social anxiety disorder. Journal of Clinical Psychopharmacology, 24(1), 49–55. doi:10.1097/01.jcp.0000104906.75206.8b
   PubMed Web of Science ®Google Scholar
• *Willutzki, U., Teismann, T., & Schulte, D. (2012). Psychotherapy for social anxiety disorder: Long-term effectiveness of resource-oriented cognitive-behavioral therapy and cognitive therapy in social anxiety disorder. Journal of Clinical Psychology, 68(6), 581–591. doi:10.1002/jclp.21842
   PubMed Web of Science ®Google Scholar
• *Wilson, J. K., & Rapee, R. M. (2005). The interpretation of negative social events in social phobia: Changes during treatment and relationship to outcome. Behaviour Research and Therapy, 43(3), 373–389. doi:10.1016/j.brat.2004.02.006
   PubMed Web of Science ®Google Scholar
• *Xu, L., Zhang, J., & Xiao, C. (2002). Psychotherapy for the clients with social intercourse difficulty. Chinese Journal of Clinical Psychology, 10(4), 287–289.
   Google Scholar
• *Yonkers, K. A., Bruce, S. E., Dyck, I. R., & Keller, M. B. (2003). Chronicity, relapse, and illness--Course of panic disorder, social phobia, and generalized anxiety disorder: Findings in men and women from 8 years of follow-up. Depression and Anxiety, 17(3), 173–179. doi:10.1002/da.10106
   PubMed Web of Science ®Google Scholar
• *Zhang, W., Connor, K. M., & Davidson, J. R. T. (2005). Levetiracetam in social phobia: A placebo controlled pilot study. Journal of Psychopharmacology, 19(5), 551–553. doi:10.1177/0269881105056526
   PubMed Web of Science ®Google Scholar